Cargando…
Newcastle disease virus degrades HIF-1α through proteasomal pathways independent of VHL and p53
Newcastle disease virus (NDV) is a candidate agent for oncolytic virotherapy. Despite its potential, the exact mechanism of its oncolysis is still not known. Recently, we reported that NDV exhibited an increased oncolytic activity in hypoxic cancer cells. These types of cells negatively affect thera...
Autores principales: | Abd-Aziz, Noraini, Stanbridge, Eric J., Shafee, Norazizah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Microbiology Society
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5203671/ https://www.ncbi.nlm.nih.gov/pubmed/27902314 http://dx.doi.org/10.1099/jgv.0.000623 |
Ejemplares similares
-
Bortezomib attenuates HIF-1- but not HIF-2-mediated transcriptional activation
por: ABD-AZIZ, NORAINI, et al.
Publicado: (2015) -
Recombinant Enterovirus 71 Viral Protein 1 Fused to a Truncated Newcastle Disease Virus NP (NPt) Carrier Protein
por: Mustafa, Suhaili, et al.
Publicado: (2020) -
Beluga whale pVHL enhances HIF-2α activity via inducing HIF-2α proteasomal degradation under hypoxia
por: Bi, Jianling, et al.
Publicado: (2017) -
Oxygen-independent degradation of HIF-α via bioengineered VHL tumour suppressor complex
por: Sufan, Roxana I, et al.
Publicado: (2009) -
Viral persistence in colorectal cancer cells infected by Newcastle disease virus
por: Chia, Suet-Lin, et al.
Publicado: (2014)